Molecular imaging of gene therapy for cancer

Gene Therapy

Volumn 11, Issue 15, 2004, Pages 1175-1187

  Shah, K ^a   Jacobs, A ^b   Breakefield, X O ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bioluminescence; FIAU; Fluorescence; MRI; PET; Virus vectors

Indexed keywords

BETA GALACTOSIDASE; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; COMPLEMENTARY DNA; CYTOSINE DEAMINASE; DEOXYCYTIDINE KINASE; DOPAMINE 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; GEMCITABINE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; MATRIX METALLOPROTEINASE INHIBITOR; MONOPHENOL MONOOXYGENASE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P53; PROTEINASE; SODIUM IODIDE SYMPORTER; SOMATOSTATIN RECEPTOR 1; THYMIDINE KINASE; THYROID PEROXIDASE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1;

BIOLUMINESCENCE; CANCER RESEARCH; CANCER THERAPY; CLINICAL TRIAL; DRUG MECHANISM; EXPRESSION VECTOR; FLUORESCENCE ANALYSIS; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; GENE THERAPY; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; MOLECULAR GENETICS; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; STEM CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FLUORESCENCE MICROSCOPY; GENE VECTOR; LUMINESCENCE; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TOMOGRAPHY;

ANIMALIA;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED; STEM CELLS; TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 4243091779     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302278     Document Type: Review

References (90)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316-333.
2. Bogdanov Jr A, Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol 1998; 16: 5-10.
3. Blasberg RG, Tjuvajev JG. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Q J Nucl Med 1999; 43: 163-169.
4. Saito Y et al. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 1982; 217: 1151-1153.
5. Tjuvajev JG et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995; 55: 6126-6132.
6. Gambhir SS et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 1999; 96: 2333-2338.
7. Reader AJ, Zweit J. Developments in whole-body molecular imaging of live subjects. Trends Pharmacol Sci 2001; 22: 604-607.
8. Herholz K, Weinherd K, Weiss WD. Validity of PET studies in brain tumors. Cerebrovasc Brain Metab Res 1990; 2: 240-265.
9. Price P. PET as a potential tool for imaging molecular mechanisms of oncology in man. Trends Mol Med 2001; 7: 442-446.
10. Gambhir S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683-693.
11. Jacobs AH et al. Molecular imaging of gliomas. Mol Imaging 2002; 1: 309-335.
12. Jacobs AH et al. Non-invasive assessment of vector-mediated gene expression in a phase I/II clinical glioma gene therapy trial by positron emission tomography. Lancet 2001; 358: 727-729.
13. Jacobs A et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vector in vivo. Cancer Res 2001; 61: 2983-2995.
14. Jacobs AH et al. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther 2003; 14: 277-297.
15. Gambhir SS et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000; 97: 2785-2790.
16. Filetti S et al. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999; 141: 443-457.
17. Boland A et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for targeted radiotherapy. Cancer Res 2000; 60: 3483-3492.
18. Spitzweg C et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Therapy 2001; 8: 1524-1531.
19. Haberkorn U. Gene therapy with sodium/iodide symporter in hepatocarcinoma. Exp Clin Endocrinol Diabetes 2001; 109: 60-62.
20. Huang M et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001; 8: 612-618.
21. Sun X et al. Quantitative imaging of gene induction in living animals. Gene Therapy 2001; 8: 1572-1579.
22. Liang Q et al. Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message positron emission tomography, following gene transfer with adenovirus. Mol Ther 2002; 6: 73-82.
23. Jacobs A, Breakefield XO, Fraefel C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: Part II. Vector systems and applications. Neoplasia 1999; 5: 402-416.
24. Tjuvajev JG et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1999; 1: 315-320.
25. deFelipe P. Polycistronic viral vectors. Curr Gene Ther 2002; 2: 355-378.
26. Jacobs A et al. Functional co-expression of HSV-1 thymidine kinase and green fluorescent protein: Implications for noninvasive imaging of transgene expression. Neoplasia 1999; 1: 154-161.
27. Doubrovin M et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci USA 2001; 98: 9300-9305.
28. Bogdanov AA, Lewin M, Weissleder R. Approaches and agents for imaging the vascular system. Adv Drug Deliv Rev 1999; 37: 279-293.
29. Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R. Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Therapy 2000; 7: 1648-1655.
30. Zalutsky MR et al. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution. Nucl Med Biol 1999; 26: 781-790.
31. Zinn KR et al. Detection and measurement of in vitro gene transfer by gamma camera imaging. Gene Therapy 2001; 8: 291-299.
32. Raben D et al. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Therapy 1996; 3: 567-580.
33. Bogdanov Jr AA, Simonova M, Weissleder R. Engineering membrane proteins for nuclear medicine: applications for gene therapy and cell tracking. Q J Nucl Med 2000; 44: 224-235.
34. Simonova M, Wall A, Weissleder R, Bogdanov Jr AA. Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells. Cancer Res 2000; 60: 6656-6662.
35. Kim YS et al. Tc-99 m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. Clin Nucl Med 1999; 24: 874-879.
36. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002; 2: 11-18.
37. Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol 2001; 29: 1237-1246.
38. Weissleder R et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6: 351-355.
39. Zimmer C et al. Tumor cell endocytosis (TCE) imaging facilitates delineation of the glioma-brain interface. Exp Neurol 1997; 143: 61-69.
40. Moore A et al. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001; 221: 244-250.
41. Ichikawa T et al. MRI of transgene expression: correlation of therapeutic gene expression. Neoplasia 2002; 4: 523-530.
42. Bogdanov A, Weissleder R. In vivo imaging of gene delivery and expression. Trends Biotechnol 2002; 20: S11-S18.
43. Weissleder R et al. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 1997; 204: 425-429.
44. Enochs WS et al. Paramagnetic metal scavenging by melanin: MR imaging. Radiology 1997; 204: 417-423.
45. Louie AY et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18: 321-325.
46. Stegman LD et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1999; 96: 9821-9826.
47. Boven E, Hendriks HR, Erkelens CA, Pinedo HM. The anti-tumour effects of the prodrugs N-1-leucyl-doxorubicin and vinglastine-isoleucinate in human ovarian cancer xenografts. Br J Cancer 1992; 66: 1044-1047.
48. van Haperen VW et al. Regulation of phosphorylation of deoxycytidine and 2′,2′-difluorodeoxycytidine (gemcitabine); effects of cytidine 5′-triphosphate and uridine 5′ -triphosphate in relation to chemosensitivity for 2′,2′ -difluorodeoxycytidine. Biochem Pharmacol 1996; 51: 911-918.
49. Blackstock AW et al. Tumor uptake and elimination of 2′,2′-difluoro-2′-deoxycytidine (gemcitavine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Clin Cancer Res 2001; 7: 3263-3268.
50. Lewin M et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410-414.
51. Josephson L, Perex M, Weissleder R. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem (Int Ed) 2001; 40: 3204-3206.
52. Chalfie M et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805.
53. Gerdes HH, Keather C. Green fluorescent protein: applications in cell biology. FEBS Lett 1996; 389: 44-47.
54. Ellenberg J, Lippincott-Schwartz J, Presley JF. Dual-colour imaging with GFP variants. Trends Cell Biol 1999; 9: 52-56.
55. Chaudhuri TR et al. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol 2001; 83: 432-438.
56. Ilyin SE, Flynn MC, Plata-Salaman CR. Fiber-optic monitoring coupled with confocal microscopy for imaging gene expression in vitro and in vivo. J Neurosci Methods 2001; 108: 91-96.
57. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2002; 2: 266-276.
58. Tsuzuki Y et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha-> hypoxia response element-> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 2000; 60: 6248-6252.
59. Kadambi A et al. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular functions and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res 2001; 61: 2402-2408.
60. Yuan F et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996; 93: 14765-14770.
61. Lubiatowski P et al. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 2002; 110: 149-159.
62. Hoshida T et al. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. Pancreas 2002; 25: 111-121.
63. Li Y et al. The role of selectins and integrins in adenovirus vector-induced neutrophil recruitment to the liver. Eur J Immunol 2002; 32: 3443-3452.
64. Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001; 19: 327-331.
65. Tung C, Bredown S, Mahmood U, Weissleder R. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjugate Chem 1999; 10: 892-896.
66. Weissleder R, Tung C-H, Mahmood U, Bogdanov Jr A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotech 1999; 17: 375-378.
67. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 2000; 60: 4953-4958.
68. Marten K et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 2002; 122: 406-414.
69. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001; 7: 743-748.
70. Shah K et al. In vivo imaging of HIV protease activity in amplicon vector transduced gliomas. Cancer Res 2004; 64: 273-278.
71. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8: 757-760.
72. Contag CH, Ross BD. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002; 16: 378-387.
73. Contag CH et al. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 41-52.
74. Wu JC, Sundaresan G, Iyer M, Gambhir SS. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 2001; 4: 297-306.
75. Sweeney TJ et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci USA 1999; 96: 12044-12049.
76. Contag CH et al. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 1995; 18: 593-603.
77. Shah K, Tang Y, Breakefield X, Weissleder R. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 2003; 22: 6865-6872.
78. Ntziachristos V, Kreis R, Boesch C, Quistorff B. Dipolar resonance frequency shifts in 1H MR spectra of skeletal muscle: confirmation in rats at 4.7 T in vivo and observation of changes postmortem. Magn Reson Med 1997; 38: 33-39.
79. Rehemtulla A et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging 2002; 1: 43-55.
80. Iyer M et al. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci USA 2001; 98: 14595-14600.
81. Aboody KS et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-12851.
82. Ourednik J et al. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 2002; 20: 1103-1110.
83. Snyder EY et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68: 33-51.
84. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995; 374: 367-370.
85. Herrlinger U et al. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 2000; 1: 347-357.
86. Lynch WP, Sharpe AH, Snyder EY. Neural stem cells as engraftable packaging lines optimize viral vector-mediated gene delivery to the CNS: evidence from studying retroviral env-related neurodegeneration. J Virol 1999; 73: 6841-6851.
87. Tang Y et al. In vivo tracking of neuronal progenitor cell migration to glioblastomas. Hum Gene Ther 2003; 14: 1247-1254.
88. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002; 99: 377-382.
89. Laxman B et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 2002; 99: 16551-16555.
90. Goldstein DJ, Weller SK. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis; isolation and characterization of an ICP6 lacZ insertion mutant. J Virol 1988; 62: 196-205.